Auto-immune disease treatment with cyclosporin g

Treatment comprises administering an effective amt. of (Nva)2- Cyclosporine or, in the case of uveitis or juvenile diabetes type I, dihydro- (val)2- Cyclosporine. (Nva)2-Cyclosporine may be used for treatment. of Myasthenia gravis, multiple sclerosis, systemise lypus, erythematosus, Haemdytic anaemi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DONATSCH PETER, HIESTAND PETER, BOREL JEAN-FRANCOIS, RYFFEL BERNHARD
Format: Patent
Sprache:eng ; ita
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Treatment comprises administering an effective amt. of (Nva)2- Cyclosporine or, in the case of uveitis or juvenile diabetes type I, dihydro- (val)2- Cyclosporine. (Nva)2-Cyclosporine may be used for treatment. of Myasthenia gravis, multiple sclerosis, systemise lypus, erythematosus, Haemdytic anaemia and Glomerulonephirtis.